| abstract |
In particular, provided are pyrazolyl-substituted pyridone compounds that exhibit biological activity, eg, inhibitory action, on serine proteases including thrombin and various kallikreins. Further provided is a pharmaceutical composition. Further provided are methods of treating and preventing certain diseases or disorders, which are suitable for treatment or prevention by inhibition of serine proteases including thrombin and various kallikreins. |